Clinical and Dopamine Transporter Imaging Characteristics of Leucine Rich Repeat Kinase 2 (LRRK2) and Glucosylceramidase Beta (GBA) Parkinson's Disease Participants in the Parkinson's Progression Markers Initiative: A Cross-Sectional Study.
Tatyana SimuniMichael C BrummLiz UribeChelsea Caspell-GarciaChristopher S CoffeyAndrew SiderowfRoy N AlcalayJohn Q TrojanowskiLeslie M ShawJohn SeibylAndrew B SingletonArthur W TogaDoug GalaskoTatiana M ForoudKelly Nicole Holohan NudelmanDuygu TosunKathleen L PostonDaniel WeintraubBrit MollenhauerCaroline M TannerKarl KieburtzLana M ChahineAlyssa ReimerSamantha HuttenSusan B BressmanKenneth Mareknull nullPublished in: Movement disorders : official journal of the Movement Disorder Society (2020)
ClinicalTrials.gov (NCT01141023). © 2020 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society.